Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
2 drugs in development
By Therapeutic Area
top 3
R&D Momentum
63/100
Pipeline Velocity
22/100
Trial Completion Rate
62/100
Pipeline Concentration
28/100
Pipeline Freshness
58/100
Strategic Signals
Activity
Last 14 days
Comparing Approaches to Assess Nitric Oxide-dependent Cutaneous Vasodilation
Role of Inflammation in Vascular Phenotype Associated With E-cigarette Use
Development and Validation of CMT Pediatric Scale for Children With Charcot Marie Tooth
Genetics of Charcot Marie Tooth Disease (CMT) - Modifiers of CMT1A, New Causes of CMT
Delineating the Effects of Transitional Circulation Physiology on Extremely Low Birth Weight (ELBW) Infants
Temporal Dynamics of Palatal Wound Healing With and Without Adjunctive Biologics in Patients With Obesity
The Effects of AFO Heel Height and Stiffness on Gait
Reliability of Force Measurement Within the Carbon Fiber Orthosis Proximal Cuff
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)